This is a non-core endpoint: only basic statistics are computed.
Crushing injury of ankle and foot
ST19_CRUSHI_INJURY_ANKLE_FOOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
133 |
4. Check minimum number of eventsNone |
133 |
5. Include endpointsNone |
133 |
6. Filter based on genotype QC (FinnGen only) |
133 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Conquassatio tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Crushing injury of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 133 | 44 | 89 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.04 |
| Median age at first event (years) | 49.65 | 48.81 | 50.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 118
- Matched controls
- 1180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S97.8
ICD-10 Finland
Crushing injury of other parts of ankle and foot
+∞
62.1
54
*
S97.1
ICD-10 Finland
Crushing injury of toe(s)
+∞
44.7
40
*
S97.0
ICD-10 Finland
Crushing injury of ankle
+∞
26.0
24
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
22.4
22.6
33
20
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
62.7
22.1
25
5
NHQ40
NOMESCO Finland
Amputation of toe
74.7
17.3
19
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
14.0
17.2
30
28
ZZA00
NOMESCO Finland
Split skin graft
19.3
14.1
21
13
NHJ50
NOMESCO Finland
Open reduction of fracture of foot or toe
+∞
13.8
13
*
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
144.8
12.7
13
*
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
15.8
12.5
20
15
SPAT1148
SPAT
Treatment of chronic ulcer or burn
6.0
11.2
33
72
W23
ICD-10 Finland
Caught, crushed, jammed or pinched in or between objects
48.3
11.2
13
*
S92.5
ICD-10 Finland
Fracture of other toe
48.3
11.2
13
*
X59
ICD-10 Finland
Exposure to unspecified factor
4.7
11.0
42
123
W31
ICD-10 Finland
Contact with other and unspecified machinery
16.3
10.9
17
12
TQW11
NOMESCO Finland
Vacuum treatment of wound
60.1
9.8
11
*
T93.6
ICD-10 Finland
Sequelae of crushing injury and traumatic amputation of lower limb
+∞
9.5
9
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.8
9.4
48
180
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
9.2
9.3
19
24
NH1AD
NOMESCO Finland
Ankle and foot CT
30.0
8.6
11
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.7
8.6
25
53
X58
ICD-10 Finland
Exposure to other specified factors
4.4
8.6
33
95
WX213
NOMESCO Finland
Lower leg blockade
+∞
8.4
8
*
J01FF01
ATC
clindamycin; systemic
3.3
7.4
45
185
A46
ICD-10 Finland
Erysipelas
4.3
7.4
28
79
S97
ICD-10 Finland
Crushing injury of ankle and foot
+∞
7.4
7
*
S92.0
ICD-10 Finland
Fracture of calcaneus
+∞
7.4
7
*
S97
ICPC
Chronic ulcer skin
8.4
7.2
15
20
W22
ICD-10 Finland
Striking against or struck by other object(s)
6.4
7.1
18
32
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
15.0
7.0
11
8
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
7.3
6.6
15
23
S92.3
ICD-10 Finland
Fracture of metatarsal bone
73.7
6.5
7
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
73.7
6.5
7
*
J01MA12
ATC
levofloxacin; systemic
3.5
6.4
32
114
S92.4
ICD-10 Finland
Fracture of great toe
+∞
6.3
6
*
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
+∞
6.3
6
*
ZXD05
NOMESCO Finland
Urgent procedure
2.8
6.0
46
218
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
32
127
3.00
6.20
2.9
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
157
2.77
5.85
2.6
2.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
49
273
2.26
4.61
4.7
5.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
32
3.66
3.41
2.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
123
1062
3.10
3.21
20.6
14.0
mg/l
27.7
23.3
0.66
103
842
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
100
2.44
3.21
2.1
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
104
2.34
2.95
2.0
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
50
332
1.81
2.65
2.7
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
7
7.36
2.57
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
60
425
1.75
2.54
15.7
9.1
inr
1.4
1.2
0.54
15
125
(3016879) Cocaine [Presence] in Urine
11
41
2.83
2.34
2.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
43
2.70
2.15
2.3
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
43
2.70
2.15
1.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
43
2.70
2.15
2.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
44
2.64
2.07
2.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
44
2.64
2.07
2.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
62
464
1.63
2.02
5.2
7.7
mmol/l
1.2
1.2
0.47
52
388
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
27
3.09
1.97
1.0
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
27
3.09
1.97
1.0
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
48
339
1.65
1.96
5.5
5.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
22
3.30
1.91
1.3
2.0
%
181.9
244.8
—
7
22
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
360
1.62
1.88
2.9
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
117
1.94
1.88
3.8
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
17
3.64
1.86
1.2
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
17
3.64
1.86
1.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
118
1.93
1.83
1.2
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
77
618
1.58
1.82
6.0
5.4
mmol/l
7.1
6.7
0.72
72
573
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
134
1.87
1.81
13.4
7.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
25
150
1.82
1.79
2.8
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
18
3.44
1.76
1.0
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
20
112
1.92
1.76
7.0
11.8
mmol/l
2.4
0.9
1.23
14
85
(3016502) Oxygen saturation in Arterial blood
19
105
1.94
1.74
7.3
12.1
%
95.2
95.2
0.00
19
99
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
19
3.26
1.68
1.2
1.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
20
115
1.87
1.64
7.0
11.4
kpa
11.0
11.9
0.51
20
108
(3044889) 12 lead EKG panel
90
759
1.57
1.63
4.1
3.9
—
—
—
0
0
(44790049)
5
14
3.67
1.63
1.0
1.7
—
—
—
0
0
(44790047)
5
14
3.67
1.63
1.0
1.7
—
—
—
0
0
(44790048)
5
14
3.67
1.63
1.0
1.7
—
—
—
0
0
(44806118)
5
14
3.67
1.63
1.0
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
15
79
2.01
1.57
4.5
7.3
mmol/l
1.8
1.3
1.23
15
73
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
27
2.68
1.53
1.0
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
89
755
1.54
1.52
4.5
3.7
mm/h
13.1
10.7
0.64
81
689
(3011397) Hemoglobin [Presence] in Urine by Test strip
33
226
1.61
1.48
4.2
3.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
17
96
1.88
1.47
8.0
13.1
g/l
126.6
122.3
0.37
17
90
(3010813) Leukocytes [#/volume] in Blood
128
1207
2.61
1.46
27.7
20.0
e9/l
6.8
6.7
0.25
123
1174
(3026361) Erythrocytes [#/volume] in Blood
128
1207
2.61
1.46
27.7
19.9
e12/l
4.6
4.6
0.28
123
1174
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
62
491
1.49
1.45
4.5
4.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
74
2.00
1.45
1.6
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
22
2.81
1.45
2.8
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
16
3.20
1.45
3.4
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
84
708
1.51
1.45
5.1
4.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
39
281
1.55
1.42
3.8
2.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
35
246
1.57
1.41
7.5
6.4
—
—
—
0
0
(3015736) pH of Urine
52
400
1.49
1.39
3.9
3.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
17
3.01
1.37
1.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
60
478
1.47
1.34
6.1
5.8
%
2.5
2.8
0.51
55
450
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
24
2.57
1.32
1.2
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
48
2.17
1.31
2.7
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
37
268
1.53
1.31
3.1
2.7
—
—
—
0
0
(3000492) Spirometry study
18
108
1.77
1.30
1.6
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
38
278
1.51
1.28
3.2
2.8
e6/l
0.4
0.6
0.23
31
203
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
79
669
1.45
1.25
3.3
3.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
42
316
1.48
1.24
3.1
2.7
ng/l
2226.8
1491.2
0.26
34
255
(3009261) Glucose [Presence] in Urine by Test strip
65
532
1.43
1.23
4.4
3.6
estimate
0.0
0.0
0.00
13
96
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
245
1.52
1.22
2.6
2.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
19
2.69
1.22
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
19
2.69
1.22
1.2
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
55
438
1.44
1.20
5.1
6.6
mmol/l
1.2
1.2
1.17
50
391
(3035350) Ketones [Presence] in Urine by Test strip
63
518
1.41
1.14
4.4
3.6
estimate
0.0
0.0
0.00
13
97
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
97
1.74
1.13
1.6
2.1
nmol/l
344.1
373.6
0.30
11
84
(3021601) Nitrite [Presence] in Urine by Test strip
63
520
1.40
1.11
5.6
4.9
estimate
0.0
0.0
0.00
13
99
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
67
559
1.40
1.11
5.4
6.9
umol/l
12.8
11.1
0.44
61
530
(3019309) Folate [Moles/volume] in Red Blood Cells
25
172
1.56
1.10
2.0
1.7
nmol/l
1104.9
1299.3
0.55
17
133
(40761535) Cells panel - Urine sediment
13
75
1.81
1.07
5.0
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
48
380
1.41
1.07
2.2
1.8
pmol/l
96.1
95.6
0.02
29
188
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
30
217
1.49
1.06
1.4
1.7
mg/l
1.0
1.4
0.66
16
174
(3013115) Eosinophils [#/volume] in Blood
64
533
1.39
1.06
5.8
6.0
e9/l
0.2
0.2
0.66
58
472
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
34
2.12
1.04
1.6
2.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
61
1.88
1.02
4.5
3.5
ng/l
147.5
219.9
0.41
11
53
(3018095) Leukocytes [#/volume] in Urine
46
365
1.40
1.00
3.5
3.4
e6/l
29.2
72.7
0.75
34
257
(3013650) Neutrophils [#/volume] in Blood by Automated count
71
606
1.37
0.99
8.5
9.3
e9/l
4.4
4.1
0.23
64
533
(3000570) Elastase.pancreatic [Mass/mass] in Stool
0
29
0.00
0.99
0.0
1.6
—
246.9
—
0
15
(3012544) pH of Venous blood
15
93
1.69
0.99
1.5
3.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
40
314
1.39
0.92
3.1
3.0
e6/l
24.6
225.9
0.48
32
237
(3001604) Monocytes [#/volume] in Blood
61
514
1.35
0.90
5.8
5.7
e9/l
0.6
0.6
0.21
55
448
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
43
1.91
0.89
1.6
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
61
515
1.34
0.89
5.8
5.8
e9/l
0.0
0.0
0.17
55
451
(3020779) Urea [Moles/volume] in Serum or Plasma
13
80
1.69
0.88
3.1
8.7
mmol/l
7.7
9.5
0.86
13
75
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
420
1.35
0.87
4.8
3.5
ng/l
70.6
45.1
0.24
35
300
(3019198) Lymphocytes [#/volume] in Blood
62
527
1.33
0.85
6.1
5.9
e9/l
1.8
1.8
0.11
55
470
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
24
0.00
0.80
0.0
5.5
—
1008.0
—
0
24
(3018418) pH of Serum or Plasma
35
276
1.36
0.78
2.7
3.8
ph
7.4
7.4
—
8
52
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
53
1.75
0.77
2.4
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
23
2.22
0.77
1.4
1.3
—
—
—
0
0
(4094501)
5
23
2.22
0.77
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
24
2.12
0.75
2.4
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
10
60
1.72
0.74
1.5
4.2
g/l
132.2
129.5
—
10
60
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
91
827
1.32
0.73
7.4
7.6
u/l
87.2
79.4
0.59
84
771
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
24
180
1.41
0.71
4.1
3.8
ng/l
307.8
151.6
0.22
18
141
(3008152) Bicarbonate [Moles/volume] in Arterial blood
11
69
1.65
0.71
12.7
13.3
mmol/l
25.5
24.5
0.45
11
62
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
111
1041
1.40
0.70
4.5
4.4
mmol/l
5.9
6.0
0.60
98
945
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
29
1.75
0.64
1.2
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
71
1.60
0.64
8.0
10.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
54
466
1.27
0.63
10.1
9.2
e9/l
0.0
0.0
0.53
47
381
(3012516) Albumin [Mass/volume] in Urine
36
295
1.30
0.62
3.1
3.4
mg/l
1403.4
94.1
0.47
25
197
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
84
765
1.27
0.61
2.9
3.8
pmol/l
14.4
14.9
0.91
74
692
(3027273) Bicarbonate [Moles/volume] in Venous blood
8
52
1.57
0.61
1.5
3.5
mmol/l
27.4
24.9
—
8
52
(3004809) Band form neutrophils/100 leukocytes in Blood
0
21
0.00
0.60
0.0
3.2
—
0.4
—
0
16
(3004588) Protein electrophoresis panel - Serum or Plasma
10
64
1.61
0.60
1.2
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
115
1092
1.39
0.60
4.7
4.9
mmol/l
2.7
2.7
0.07
101
1007
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
108
1017
1.33
0.59
15.6
12.4
ml/min/173m2
84.4
83.6
0.13
88
811
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
161
1.36
0.56
2.3
2.7
e6/l
0.6
2.3
1.42
12
95
(3000330) Specific gravity of Urine by Test strip
9
60
1.54
0.56
1.8
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
93
1.44
0.50
7.8
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
29
238
1.28
0.50
4.6
4.2
kg/l
1.0
1.0
—
5
33
(3009542) Hematocrit [Volume Fraction] of Blood
104
982
1.27
0.49
22.4
13.9
%
39.7
40.5
0.31
69
712
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
102
962
1.26
0.48
3.9
4.3
mu/l
2.0
1.9
0.28
91
875
(21494755) Public health laboratory ask at order entry panel
8
116
0.67
0.48
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
7
48
1.48
0.47
1.0
1.0
—
—
—
0
0
(4010399)
11
78
1.45
0.44
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
32
1.58
0.42
2.2
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
44
386
1.21
0.42
2.2
2.2
nmol/l
73.7
72.7
0.08
38
336
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
33
1.53
0.42
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
36
310
1.22
0.41
3.2
3.2
mmol/l
7.2
8.0
0.47
29
261
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
142
1.31
0.41
1.3
1.3
iu/ml
22.7
43.0
—
5
53
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
21
171
1.27
0.39
2.4
2.5
e6/l
0.8
0.8
0.04
12
104
(40761511) CBC panel - Blood by Automated count
117
1130
1.29
0.38
19.3
13.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
43
1.41
0.35
1.7
1.8
—
—
—
0
0
(3020891) Body temperature
6
46
1.32
0.33
10.0
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
74
1.38
0.33
5.9
8.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
104
998
1.19
0.32
7.1
5.7
mmol/mol
40.3
40.2
0.03
94
937
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
54
1.31
0.31
10.3
18.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
122
1.26
0.28
2.7
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
35
312
1.17
0.28
3.7
4.3
mg/mmol
7.1
16.5
1.27
23
206
(3022621) pH of Urine by Test strip
10
77
1.32
0.27
2.3
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
16
133
1.23
0.25
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
29
257
1.16
0.25
3.5
5.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
33
296
1.15
0.24
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
95
0.72
0.23
1.3
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
5
39
1.29
0.23
6.6
17.0
%
1.0
0.9
—
5
34
(4034850)
5
40
1.26
0.22
7.2
12.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
101
0.78
0.22
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
42
1.20
0.21
6.6
15.9
%
1.5
1.6
—
5
36
(40768795) Lymph node Pathology biopsy report
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
1.9
—
0
11
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
38.4
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
478.0
—
0
5
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
267.6
—
0
5
(4062490)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
10
0.00
0.21
0.0
2.7
—
89.7
—
0
10
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
39
423
0.89
0.20
2.4
2.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
48
1.26
0.20
1.5
2.7
%
1.7
1.4
—
6
48
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
176
1.16
0.18
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
19
215
0.86
0.18
2.1
1.8
pmol/l
411.7
424.3
0.08
13
180
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
60
1.18
0.18
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
68
0.73
0.17
1.4
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
306
0.89
0.16
2.8
2.9
ug/l
0.5
0.7
0.84
17
193
(3015377) Calcium [Moles/volume] in Serum or Plasma
36
334
1.11
0.16
2.0
3.5
mmol/l
2.3
2.3
0.13
30
292
(3019225) pH of Specimen
12
103
1.18
0.14
2.6
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
109
1068
1.11
0.14
4.5
4.4
mmol/l
4.5
4.6
0.41
99
993
(3019832) Treponema pallidum Ab [Presence] in Serum
9
105
0.85
0.13
2.0
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
44
416
1.09
0.13
5.5
3.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
14
158
0.87
0.13
1.3
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
106
1039
1.10
0.12
3.9
4.0
mmol/l
1.3
1.3
0.29
94
956
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
208
0.90
0.11
2.3
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
45
1.12
0.10
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
47
1.07
0.09
1.0
1.3
u/ml
243.0
215.5
—
5
39
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
5
60
0.83
0.08
2.8
2.5
mmol/l
3.7
1.5
—
5
44
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
64
0.77
0.08
2.8
2.5
kpa
5.6
5.1
—
5
58
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
108
1065
1.07
0.07
4.3
4.3
mmol/l
1.3
1.4
1.10
97
986
(3029937) Albumin [Presence] in Urine by Test strip
30
285
1.07
0.07
6.9
3.9
estimate
0.0
0.0
0.00
12
91
(36660697) Celiac disease serology panel - Serum
7
84
0.82
0.07
1.4
1.1
—
—
—
0
0
(3013512) EKG study
33
317
1.05
0.05
5.7
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
41
397
1.05
0.05
1.8
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
308
1.05
0.05
4.6
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
55
539
1.03
0.03
4.0
4.6
ug/l
1.2
2.7
1.65
49
482
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
77
781
0.97
0.03
3.7
3.4
u/l
83.3
52.4
0.94
71
729
(3002256) Pathology report gross observation
11
118
0.93
0.03
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
22
228
0.96
0.02
1.3
1.2
u/ml
0.6
0.9
—
7
69
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
109
1.01
0.00
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
111
0.99
0.00
1.9
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
21
209
1.01
0.00
1.4
1.4
g/l
3.2
2.7
0.55
14
135
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
43
432
0.99
0.00
3.7
4.2
%
25.7
20.9
0.87
14
200
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
138
1.02
0.00
3.1
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13
125
1.04
0.00
1.3
1.4
u/ml
1.1
14.7
—
8
58
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
71
0.99
0.00
1.3
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
5.7
—
25.4
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
1.4
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
1.8
—
11.8
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.4
—
0.6
—
0
7
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1559.0
—
0
6
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
4.6
—
157.9
—
0
7
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1211.8
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
73
0.96
0.00
1.0
1.6
—
—
—
0
0
(4024509)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.2
—
10944.8
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
13.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
10.2
—
26.1
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_CRUSHI_INJURY_ANKLE_FOOT – Crushing injury of ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).